LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 50

Search options

  1. Article ; Online: Covid-19 and exacerbation of psoriasis.

    Ozaras, Resat / Berk, Ahmet / Ucar, Dilek Hasman / Duman, Habibe / Kaya, Fatma / Mutlu, Huseyin

    Dermatologic therapy

    2020  Volume 33, Issue 4, Page(s) e13632

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Humans ; Hydroxychloroquine ; Oseltamivir ; Pandemics ; Pneumonia, Viral ; Psoriasis/diagnosis ; SARS-CoV-2
    Chemical Substances Oseltamivir (20O93L6F9H) ; Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-06-02
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/dth.13632
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Covid19 and exacerbation of psoriasis

    Ozaras, Resat / Berk, Ahmet / Ucar, Dilek Hasman / Duman, Habibe / Kaya, Fatma / Mutlu, Huseyin

    Dermatologic Therapy

    2020  Volume 33, Issue 4

    Keywords Dermatology ; General Medicine ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/dth.13632
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.

    Arifin, Aisyah N F / Hengky, Antoninus / Widjaja, Maureen / Wijaya, Lorettha

    Indian journal of dermatology

    2024  Volume 68, Issue 6, Page(s) 724

    Abstract: ... the following MeSH terms: "psoriasis," "exacerbation," "induced psoriasis," and "COVID-19 vaccination ... Although the cases of new-onset and exacerbation of psoriasis after COVID-19 vaccination is quite scarce ... to that condition following COVID-19 vaccination.: Materials and methods: Three databases were utilised, namely ...

    Abstract Introduction: Although uncommon, several cases of new-onset and exacerbation of psoriasis have been reported after coronavirus disease 2019 (COVID-19) vaccination. This study aims to systematically review reports regarding new-onset and exacerbation of psoriasis to identify features related to that condition following COVID-19 vaccination.
    Materials and methods: Three databases were utilised, namely, PubMed, Google Scholar, and EBSCOHost to search for literature published until June 2022. We used the following MeSH terms: "psoriasis," "exacerbation," "induced psoriasis," and "COVID-19 vaccination." The included literature must report the case/(s) of psoriasis exacerbation in previously-in-remission or induced psoriasis in individuals receiving any dose of COVID-19 vaccines regardless of the type.
    Results: Among 33 selected studies, an overall mean age was 57.52 ± 15.92 years. Female (
    Conclusions: Although the cases of new-onset and exacerbation of psoriasis after COVID-19 vaccination is quite scarce, the possibility of occurrence should be acknowledged and managed properly; and patients should be informed, particularly ones with history of psoriasis without discouraging patients to take vaccine.
    Language English
    Publishing date 2024-01-09
    Publishing country India
    Document type Journal Article
    ZDB-ID 416069-1
    ISSN 1998-3611 ; 0019-5154
    ISSN (online) 1998-3611
    ISSN 0019-5154
    DOI 10.4103/ijd.ijd_833_22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters.

    Karampinis, Emmanouil / Papadopoulou, Myrto-Maria / Chaidaki, Kleoniki / Georgopoulou, Konstantina-Eirini / Magaliou, Stavroula / Roussaki Schulze, Angeliki Viktoria / Bogdanos, Dimitrios P / Zafiriou, Efterpi

    Vaccines

    2024  Volume 12, Issue 2

    Abstract: ... on psoriasis flares following COVID-19 vaccination are primarily obtained by combining exposome and vaccine ... state induced by the COVID-19 vaccine. Analyzing interactions between vaccine-induced phenomena and ... assessed the COVID-19 vaccine-induced plaque psoriasis in terms of clinical presentation, post-vaccination ...

    Abstract The diverse patient population and widespread vaccination in the COVD-19 era make vaccine-triggered episodes of psoriasis an ideal model of exposome research. This scenario explores the fine balance between protective and exacerbating factors, providing insights into the complex relationship between environmental exposure and psoriasis immunopathogenesis when a trigger appears, such as that of the hyperinflammatory state induced by the COVID-19 vaccine. Analyzing interactions between vaccine-induced phenomena and exposome parameters may provide clinically relevant information important for personalized medicine decision-making. We performed a literature review seeking patients with plaque psoriasis flares or new onset or change in plaque psoriasis into another psoriasis subtype, such as pustular or erythrodermic flare, focusing on the inner and external exposome traits of patients. We identified 71 patients with plaque psoriasis flares, 12 patients with new-onset psoriasis, and 17 with plaque psoriasis subtype change, and assessed the COVID-19 vaccine-induced plaque psoriasis in terms of clinical presentation, post-vaccination flare period and treatment status, as well as inner exposome parameters (genomics, oxidative stress, hormonal impact due to gender, aging, skin color) and external parameters (UV, infectomics). Novel data on psoriasis flares following COVID-19 vaccination are primarily obtained by combining exposome and vaccine-triggered episode features and characteristics and comparing them with similar psoriasis flares unrelated to COVID-19 vaccination.
    Language English
    Publishing date 2024-02-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines12020178
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.

    Potestio, Luca / Battista, Teresa / Cacciapuoti, Sara / Ruggiero, Angelo / Martora, Fabrizio / Fornaro, Luigi / Camela, Elisa / Megna, Matteo

    Biomedicines

    2023  Volume 11, Issue 8

    Abstract: ... psoriasis or the exacerbation of psoriasis following COVID-19 vaccination. However, data on the possible ... COVID-19 vaccination was the main measure to overcome the pandemic. As with other drugs and ... of our manuscript was to perform a review of the current literature on post-COVID-19 vaccination exacerbations and ...

    Abstract COVID-19 vaccination was the main measure to overcome the pandemic. As with other drugs and vaccines, mild to moderate adverse events have been reported following vaccination. In addition, several cutaneous reactions have been described. In particular, there are several reports investigating de novo psoriasis or the exacerbation of psoriasis following COVID-19 vaccination. However, data on the possible pathogenetic mechanisms as well as comprehensive manuscripts on the topic are scant. Thus, the aim of our manuscript was to perform a review of the current literature on post-COVID-19 vaccination exacerbations and new-onset psoriasis in order to offer a wide perspective on this area and to point out possible pathogenetic mechanisms. Research on the current literature was performed following PRISMA guidelines. In total, 49 studies involving 134 patients developing new-onset psoriasis (
    Language English
    Publishing date 2023-08-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11082191
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: New onset and exacerbation of psoriasis after COVID-19 vaccination.

    Wei, Nancy / Kresch, Mindy / Elbogen, Emily / Lebwohl, Mark

    JAAD case reports

    2021  Volume 19, Page(s) 74–77

    Language English
    Publishing date 2021-11-29
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2834220-3
    ISSN 2352-5126
    ISSN 2352-5126
    DOI 10.1016/j.jdcr.2021.11.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis-A case series and mini review.

    Ständer, Sascha / Zirpel, Henner / Bujoreanu, Florin / Tatu, Alin Laurentiu / Ludwig, Ralf J / Thaçi, Diamant

    Frontiers in medicine

    2022  Volume 9, Page(s) 995150

    Abstract: Recently, COVID-19 vaccination-induced exacerbation or new-onset of psoriasis have been reported ... to the understanding of COVID-19 vaccination-triggered psoriasis, we report five cases with exacerbation or new-onset ... patient with psoriatic arthritis required systemic treatment. New onset and exacerbation of psoriasis have ...

    Abstract Recently, COVID-19 vaccination-induced exacerbation or new-onset of psoriasis have been reported. Underlying immune pathogenesis is unclear and different mechanisms are assumed. Further, clinical- and vaccine-related features and characteristics are partly inconsistent and remain to be elucidated. To add to the understanding of COVID-19 vaccination-triggered psoriasis, we report five cases with exacerbation or new-onset of psoriasis. In our cohort, one patient experienced the new onset of psoriasis, while four had an exacerbation following COVID-19 vaccination. In most patients, exacerbation or new onset occurred after the 2nd or 3rd vaccination. The mean latency from the day of vaccination was 7.2 (1.8) days (SD). The clinical impact with a mean PASI increase following COVID-19 vaccination of 7.2 (5.6) was considered relevant. In most cases, psoriatic lesions almost cleared after applying topical steroids in addition to current treatment, while one patient with psoriatic arthritis required systemic treatment. New onset and exacerbation of psoriasis have also been noted following COVID-19 infections. Hence, the underlying inflammatory response is most likely the culprit agent triggering psoriasis. This underscores that the benefits of COVID-19 vaccination far outweigh the risks, as also in patients with psoriasis.
    Language English
    Publishing date 2022-09-26
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.995150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases.

    Bostan, Ecem / Elmas, Leyla / Yel, Beril / Yalici-Armagan, Basak

    Dermatologic therapy

    2021  Volume 34, Issue 6, Page(s) e15110

    MeSH term(s) BNT162 Vaccine ; COVID-19 ; COVID-19 Vaccines ; Humans ; Psoriasis/diagnosis ; Psoriasis/genetics ; RNA, Messenger ; SARS-CoV-2
    Chemical Substances COVID-19 Vaccines ; RNA, Messenger ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2021-08-30
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/dth.15110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

    Kutlu, Ömer / Metin, Ahmet

    Dermatologic therapy

    2020  Volume 33, Issue 4, Page(s) e13383

    MeSH term(s) Aged ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; COVID-19 ; Coronavirus Infections/drug therapy ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Hydroxychloroquine/adverse effects ; Oseltamivir/administration & dosage ; Oseltamivir/adverse effects ; Pandemics ; Pneumonia, Viral/drug therapy ; Psoriasis/etiology ; Psoriasis/pathology
    Chemical Substances Antiviral Agents ; Oseltamivir (20O93L6F9H) ; Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-04-24
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/dth.13383
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top